Kimer Med

Valvatna, Vestland, Norway

https://kimermed.co.nz

Company profile

Kimer Med company profile

Kimer Med is developing a family of broad-spectrum antiviral therapeutics. Our first targets are the Dengue virus and pandemic preparedness. We closed our Series A capital raise in Oct 2024.

Business identity

Website: https://kimermed.co.nz
Contact email: [email protected]
Operating status: Active
Company type: For Profit
Employee range: 00001-00010 employees
Founded: 2020-08-13

LinkedIn Facebook X

Headquarters

Headquarters: Valvatna, Vestland, Norway
Country code: NO
Continent: Europe

Capital profile

Funding and company signals

Funding stage: Early Stage Venture
Funding rounds: 7
Total equity funding: $11.6M
Last funding: Grant / $6.7K / 2024-07-01
Last equity funding: Series A / $8.7M
Investors: 1
Lead investors: 1
Founders: 2
Articles: 9

Categories and groups

Biopharma Biotechnology Therapeutics Biotechnology Health Care Science and Engineering

Founders and investors

Founders

Philip OliverRichard Kiessig

Lead investors

Callaghan Innovation

Investors

Callaghan Innovation

People at this company

Preview only. Contact details are available after you sign in.

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Shipment records and coverage can change as the dataset is updated.